HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sotnikov, I. Articles by Lider, O. Search for Related Content PubMed PubMed Citation Articles by Sotnikov, I. Articles by Lider, O.

Enzymatically Quiescent Heparanase Augments T Cell Interactions with VCAM-1 and Extracellular Matrix Components under Versatile Dynamic Contexts¹

Ilya Sotnikov^*, Rami Hershkoviz, Valentin Grabovsky^*, Neta Ilan, Liora Cahalon^*, Israel Vlodavsky, Ronen Alon^* and Ofer Lider^2,*

^* Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel; The Sakler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel; and Cancer and Vascular Biology Research Center, The Bruce Rappaport Faculty of Medicine, Technion, Internal Medicine, Haifa, Israel

During their migration into inflammatory sites, immune cells, such as T cells, secrete extracellular matrix (ECM)-degrading enzymes, such as heparanase, which, under mildly acidic conditions, degrade heparan sulfate proteoglycans (HSPG). We have previously shown that at pH 7.2, human placental heparanase loses its enzymatic activity, while retaining its ability to bind HSPG and promote T cell adhesion to unfractionated ECM. We now demonstrate that the 65-kDa recombinant human heparanase, which is devoid of enzymatic activity, but can still bind HSPG, captures T cells under shear flow conditions and mediates their rolling and arrest, in the absence or presence of stromal cell-derived factor 1 (SDF-1; CXCL12), in an ₄₁-VCAM-1-dependent manner. Furthermore, heparanase binds to and induces T cell adhesion to key ECM components, like fibronectin and hyaluronic acid, in ₁ integrin- and CD44-specific manners, respectively, via the activation of the protein kinase C and phosphatidylinositol 3-kinase intracellular signaling machineries. Although the nature of the putative T cell heparanase-binding moiety is unknown, it appears that heparanase exerts its proadhesive activity by interacting with the T cells’ surface HSPG, because pretreatment of the cells with heparinase abolished their subsequent response to heparanase. Also, heparanase augmented the SDF-1-triggered phosphorylation of Pyk-2 and extracellular signal-regulated kinase-2 implicated in integrin functioning. Moreover, heparanase, which had no chemotactic effect on T cells on its own, augmented the SDF-1-induced T cell chemotaxis across fibronectin. These findings add another dimension to the known versatility of heparanase as a key regulator of T cell activities during inflammation, both in the context of the vasculature and at extravascular sites.

This article has been cited by other articles:

				L. Fux, N. Feibish, V. Cohen-Kaplan, S. Gingis-Velitski, S. Feld, C. Geffen, I. Vlodavsky, and N. Ilan Structure-Function Approach Identifies a COOH-Terminal Domain That Mediates Heparanase Signaling Cancer Res., March 1, 2009; 69(5): 1758 - 1767. [Abstract] [Full Text] [PDF]

				V. Cohen-Kaplan, I. Doweck, I. Naroditsky, I. Vlodavsky, and N. Ilan Heparanase Augments Epidermal Growth Factor Receptor Phosphorylation: Correlation with Head and Neck Tumor Progression Cancer Res., December 15, 2008; 68(24): 10077 - 10085. [Abstract] [Full Text] [PDF]

				G. E. Bertolesi, G. Michaiel, and S. McFarlane Two Heparanase Splicing Variants with Distinct Properties Are Necessary in Early Xenopus Development J. Biol. Chem., June 6, 2008; 283(23): 16004 - 16016. [Abstract] [Full Text] [PDF]

				R. J. Wood and M. D. Hulett Cell Surface-expressed Cation-independent Mannose 6-Phosphate Receptor (CD222) Binds Enzymatically Active Heparanase Independently of Mannose 6-Phosphate to Promote Extracellular Matrix Degradation J. Biol. Chem., February 15, 2008; 283(7): 4165 - 4176. [Abstract] [Full Text] [PDF]

				A. M. de Mestre, M. A. Staykova, J. R. Hornby, D. O. Willenborg, and M. D. Hulett Expression of the heparan sulfate-degrading enzyme heparanase is induced in infiltrating CD4+ T cells in experimental autoimmune encephalomyelitis and regulated at the level of transcription by early growth response gene1 J. Leukoc. Biol., November 1, 2007; 82(5): 1289 - 1300. [Abstract] [Full Text] [PDF]

				K. Mahtouk, D. Hose, P. Raynaud, M. Hundemer, M. Jourdan, E. Jourdan, V. Pantesco, M. Baudard, J. De Vos, M. Larroque, et al. Heparanase influences expression and shedding of syndecan-1, and its expression by the bone marrow environment is a bad prognostic factor in multiple myeloma Blood, June 1, 2007; 109(11): 4914 - 4923. [Abstract] [Full Text] [PDF]

				A. Zetser, Y. Bashenko, E. Edovitsky, F. Levy-Adam, I. Vlodavsky, and N. Ilan Heparanase Induces Vascular Endothelial Growth Factor Expression: Correlation with p38 Phosphorylation Levels and Src Activation Cancer Res., February 1, 2006; 66(3): 1455 - 1463. [Abstract] [Full Text] [PDF]